The global peptide synthesis market size is expected to reach
USD 1,011.99 million by 2026 growing at a CAGR of 13.0%, according to a new
report by Grand View Research, Inc. Significant research and innovation
targeted towards the development of peptide therapeutics is set to boost the
market growth in the near future. Additionally, increasing advancements in the
peptide synthesis technologies is expected to offer profitable opportunities
for the companies operating in the market.
A surge in the demand for
custom peptide synthesis has been observed in the recent years; several
companies operating in this industry offer products and services associated
with custom peptide synthesis. For instance, a UK based company namely, Almac
Group offers peptide synthesis suitable for research use. Constantly growing
demand and evolving market landscape for custom peptides is set to offer
lucrative opportunities for the market growth. The suppliers are expanding
their production capacity to suffice the increasing demand for high quality
peptides across research and therapeutics areas.
Rising focus of the
pharmaceutical companies towards the development of novel biologics and
shifting the peptide drugs from the pipeline stage to commercial scale further
strengthens the market growth. Increase in the number of research activities
performed on exploring the potential of high-quality peptides and peptide
libraries in the development of vaccines and biomarker discovery heavily
contributes to the revenue generated by the global peptide synthesis market.
Moreover, introduction of modified peptides (GMP peptides) that possess
enhanced stability and pharmacokinetic properties in the market is expected to
maintain the double-digit market growth throughout the forecast period.
Therapeutic peptide
development has witnessed remarkable growth in the recent years, this is
further driven by significant increase in the patient pool suffering from
cardiovascular and metabolic diseases. This has propelled the discovery of
bioactive peptides exponentially which further drives the market demand.
Browse full research report on Peptide Synthesis Market: https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market
Further key findings from the study
suggest:
- Reagents
& consumables accounted for the highest revenue generated in 2018 and
is anticipated to maintain this trend throughout the forecast period.
- Peptide
synthesis equipment has registered fastest growth during the forecast
period.
- Peptide
synthesizers segment serves to be a major contributor to the revenue
generated by equipment in the global market and is anticipated to grow at
highest CAGR of 13.91% from 2019-2026 among other peptide synthesis
equipment.
- Liquid
phase peptide synthesis (LPPS) technology dominated the peptide synthesis
market in 2018 and is expected to continue this dominance throughout the
forecast period.
- Therapeutic
peptide synthesis has garnered largest share in the market in 2018 and is
anticipated to maintain this trend throughout the forecast period.
- North
America region has generated highest revenue in 2018 and is expected to
maintain this dominance throughout the forecast period; sufficient
presence of skilled professionals along with the strong network of peptide
synthesis manufacturers is attributive to this region’s dominance in the
global market.
- APAC
is expected to offer lucrative opportunities for the market expansion,
attributed to rising focus on the development of peptide therapeutics.
- Large
patient pool for cardiovascular and metabolic diseases in the APAC region
has significantly contributed to the revenue generated, contributing to
the highest CAGR registered during the forecast period.
- Some
of the key market participants are Genscript Biotech, Merck KGaA, Bachem
Holdings, Biotage, CEM Corporation, Thermo Fisher, and Novo Nordisk among
others.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market/request/rs1
Grand View Research has segmented the global peptide
synthesis market on the basis of product, technology, application, end-use, and
region:
Peptide Synthesis Product Outlook
(Revenue, USD Million, 2014 - 2026)
- Equipment
- Peptide
Synthesizers
- Lyophilizers
- Chromatography
Equipment
- Others
- Reagents
& Consumables
- Other
Peptide Synthesis Technology Outlook
(Revenue, USD Million, 2014 - 2026)
- Solid
Phase Peptide Synthesis (SPPS)
- Liquid
Phase Peptide Synthesis (LPPS)
- Hybrid
Technology
Peptide Synthesis Application Outlook
(Revenue, USD Million, 2014 - 2026)
- Therapeutics
- Cancer
- Metabolic
- Cardiovascular
Disorder
- Respiratory
- GIT
(Gastrointestinal Disorders)
- Infectious
Diseases
- Pain
- Dermatology
- CNS
- Renal
- Others
- Diagnosis
- Research
Peptide Synthesis End-use Outlook
(Revenue, USD Million, 2014 - 2026)
- Pharmaceutical
& Biotechnology Companies
- Contract
Development & Manufacturing Organization/Contract Research
Organization
- Academic
& Research Institutes
Peptide Synthesis Regional Outlook
(Revenue, USD Million, 2014 - 2026)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Asia
Pacific
- Japan
- China
- India
- Australia
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
- Saudi
Arabia
About
Grand View Research
Grand View Research, Inc.
is a U.S. based market research and consulting company, registered in the State
of California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment